Estratest H.S. Alternatives Compared
| Estratest H.S. | Venlafaxine | Gabapentin |
|
|---|
| Estratest H.S. esterified estrogens / methyltestosterone | Venlafaxine | Gabapentin |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescribed for Hot Flashes, Menopausal Disorders, Postmenopausal Symptoms. Estratest H.S. may also be used for purposes not listed in this medication guide. |
Venlafaxine is an antidepressant that may also be used for mood disorders and off-label for some other conditions such as hot flashes. It may cause a discontinuation syndrome if abruptly stopped... View more |
Gabapentin may be used in the treatment of partial-onset seizures and nerve pain but is likely to cause dizziness or drowsiness. Gabapentin enacarbil (brand name Horizant), a prodrug of gabapentin... View more |
Choose a suggestion below |
|||||||||||||||
| More about (esterified estrogens / methyltestosterone) | More about Venlafaxine | More about Gabapentin | ||||||||||||||||
| Generic Status | ||||||||||||||||||
| Availability | ||||||||||||||||||
|
Prescription only |
Prescription only |
Prescription only |
||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Estratest H.S. has an average rating of 9.8 out of 10 from a total of 8 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Venlafaxine has an average rating of 6.4 out of 10 from a total of 2551 ratings on Drugs.com. 53% of reviewers reported a positive effect, while 28% reported a negative effect. |
Gabapentin has an average rating of 7.1 out of 10 from a total of 2317 ratings on Drugs.com. 64% of reviewers reported a positive effect, while 21% reported a negative effect. |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Side Effects | ||||||||||||||||||
|
See the full Estratest H.S. side effects document. |
Commonly reported side effects include: anorgasmia, asthenia, constipation, dizziness, drowsiness, insomnia, nausea, nervousness, headache, anorexia, decreased appetite, delayed ejaculation, diaphoresis, xerostomia. See the full venlafaxine side effects document. |
Commonly reported side effects include: ataxia, dizziness, drowsiness, fatigue, fever, nystagmus disorder, sedated state, viral infection. See the full gabapentin side effects document. |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all venlafaxine prices |
View all gabapentin prices |
||||||||||||||||
| Dosage Form(s) Available | ||||||||||||||||||
| N/A |
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Other esterified estrogens / methyltestosterone brands include: Covaryx, Covaryx HS, EEMT, EEMT HS | Effexor, Effexor XR | Fanatrex, Gabarone, Gralise, Neurontin | ||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
|
N/A |
4 hours |
6 hours |
||||||||||||||||
| CSA Schedule** View glossary of terms | ||||||||||||||||||
|
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category X
Not for use in pregnancy
See the full Pregnancy Warnings document. |
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 221 drugs are known to interact with Estratest H.S.:
|
A total of 658 drugs are known to interact with venlafaxine:
|
A total of 264 drugs are known to interact with gabapentin:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
|
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
|
||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
N/A |
December 28, 1993 |
December 30, 1993 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
|
N/A |
N/A |
|||||||||||||||||
| More Information | ||||||||||||||||||
| Patient resources | ||||||||||||||||||
|
N/A |
||||||||||||||||||
| Professional Resources | ||||||||||||||||||
|
N/A |
||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
|
|
|||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.